Nutritional Supplements to Support Recovery After Foot Surgery - A Pilot Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Foot Injuries and Disorders
- Sponsor
- NutraHeal
- Enrollment
- 46
- Locations
- 2
- Primary Endpoint
- Wound Healing at 3 weeks after surgery
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This is a prospective randomized trial wherein participants will be assigned to NutraHeal™, NutraHeal Plus™, or standard of care for 1 week prior to foot surgery and 3 weeks after surgery. The central hypothesis is that among patients undergoing surgery, nutritional supplements that maintain energy production, muscle structure, immune function, and response to pain will support recovery from surgery.
Detailed Description
Over a 6 month period the investigators will enroll 45 male and female patients undergoing foot surgery. This is a prospective randomized trial and participants will be assigned to NutraHeal™ (n=15), NutraHeal Plus™ (n=15), or standard of care (n=15) for 1 week prior to surgery and 3 weeks after surgery. NutraHeal™ is a nutritional supplement that contains 7.5 micrograms (300 IU) of Vitamin D3, 80 mg of Calcium as Calcium Hydroxymethylbutyrate Monohydrate, 7.5 mg of Zinc, 600 mg of Calcium Hydroxymethylbutyrate Monohydrate, and 45 mg of Bromelain. NutraHeal Plus™ is a nutritional supplement that contains 80 mg of Calcium as Calcium Hydroxymethylbutyrate Monohydrate, 7.5 mg of Zinc, 600 mg of Calcium Hydroxymethylbutyrate Monohydrate, 45 mg of Bromelain, and 7.5 mg of reduced Nicotinamide Adenine Dinucleotide (NADH). Patients randomized to standard of care will not receive any of the ingredients in NutraHeal™ or NutraHeal Plus™. The foot surgeon will evaluate the patient for wound healing time, healing quality, erythema and new tissue quality, using a Likert rating scale against expected results from -4 (much worse) to +4 (much better) including the expected reference grade of zero (0). Wound healing will be assessed at 1 and 3 weeks after surgery. Patients will document medication compliance (day of surgery, 1 and 3 weeks after surgery), pain medication use (baseline, on the day of surgery and at 1 and 3 weeks after surgery) and rate overall satisfaction (5-point scale (1 = excellent; 2 = good; 3 = moderate; 4 = sufficient; 5 = unsatisfactory) at 3 weeks after surgery). Patients will also complete the PROMIS-29 instrument at baseline, the day of surgery, and at 1 and 3 weeks after surgery).
Investigators
Eligibility Criteria
Inclusion Criteria
- •≥ 20 years of age
- •Undergoing foot surgery (matrixectomy (ingrown toenail removal) and wart removal)
Exclusion Criteria
- •\> 80 years of age
- •Pregnant patients or those anticipating pregnancy in the 1 month study period
- •Allergic to pineapple
- •Treated with oral anticoagulation
- •Currently receiving Bromelain, Hydroxymethylbutyrate Monohydrate (HMB), reduced Nicotinamide Adenine Dinucleotide (NADH), Vitamin D3, or Zinc.
- •Alcoholism (\>2 drinks/day)
- •Insulin Dependent Diabetes
- •Hepatic insufficiency (prior known liver function tests \> 1.5 times the upper limit of normal)
- •Renal failure (prior known creatinine \> 2.0 mg/dl)
- •Severe pulmonary disease (requiring home oxygen therapy)
Outcomes
Primary Outcomes
Wound Healing at 3 weeks after surgery
Time Frame: 3 weeks after surgery.
Wound healing (time, healing quality, erythema and new tissue quality), using a Likert rating scale against expected results from -4 (much worse) to +4 (much better) including the expected reference grade of zero (0). Positive scores are a better outcome.
Secondary Outcomes
- Pain Intensity(Baseline, the day of surgery, and at 1 and 3 weeks after surgery.)
- Pain Interference(Baseline, the day of surgery, and at 1 and 3 weeks after surgery.)
- Fatigue(Baseline, the day of surgery, and at 1 and 3 weeks after surgery.)
- Wound Healing at 1 week after surgery(1 week after surgery)